Bristol-Myers Discontinues Hepatitis C Drug
Bristol-Myers Squibb Co has announced it is stopping development of its experimental hepatitis C drug after one patient died due to heart failure and 9 others were hospitalized. Two patients remain hospitalized.
Bristol Will Follow Up on All Participants
Bristol acquired the drug, BMS-986094, after its $2.5 billion acquisition of Inhibitex Inc. The class the drug belongs to, nucleotide polymerase inhibitors, is seen as being very promising in future treatments of hepatitis C.
Reports of the possible dangers of this drug emerged after phase II of the clinical trial was stopped on August 1, 2012 due to reports that at least one person suffered sudden heart failure. The person died soon after.
Everyone that participated in the trial will be monitored by Bristol, with help from the U.S. Food and Drug Administration (FDA) and trial investigators. The two patients that remain hospitalized are having issues of heart and kidney toxicity. Bristol has stated it will continue its investigation of the drug to find out the cause of the drug’s toxicity, Philly.com is reporting.
Clinical Trial of Similar Drug Put on Hold
Another experimental hepatitis C drug, by Idenix Pharmaceuticals Inc, has had its trial put on hold after heart-related problems showed up in some patients.
More than 15,000 Americans die each year due to hepatitis C, which is transmitted through the blood. It is also the main cause of liver transplants in the United States. For more information on hepatitis C, go here.
Contact an Experienced Drug Recall Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We are available 24/7, nights and weekends.